Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/217477
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Extracellular granzyme A promotes colorectal cancer development by enhancing gut inflammation |
Autor: | Santiago, Llipsy CSIC ORCID; Castro, Marta; Sanz-Pamplona, Rebeca; Garzón, Marcela; Ramírez-Labrada, Ariel; Tapia, Elena; Moreno, Víctor; Layunta, Elena; Gil-Gómez, Gabriel; Garrido, Marta; Peña, Raúl; Lanuza, Pilar M. CSIC ORCID; Comas, Laura CSIC ORCID; Jaime Sánchez, Paula; Uranga Murillo, Iratxe; Campo, Rosa del; Pelegrín, Pablo; Camerer, Eric; Martínez-Lostao, Luis CSIC ORCID CVN; Muñoz, Guillermo; Uranga, José A.; Alcalde, Anabel; Gálvez Buerba, Eva Mª CSIC ORCID ; Ferrández, Ángel; Bird, Phillip I.; Metkar, Sunil; Arias, Maykel CSIC ORCID; Pardo, Julián | Palabras clave: | Granzyme Extracellular Gut Colorectal cancer Inflammation STAT3 IL6 Macrophage |
Fecha de publicación: | 7-jul-2020 | Editor: | Cell Press Elsevier BV |
Citación: | Cell Reports 32(1): 107847 (2020) | Resumen: | If not properly regulated, the inflammatory immune response can promote carcinogenesis, as evident in colorectal cancer (CRC). Aiming to gain mechanistic insight into the link between inflammation and CRC, we perform transcriptomics analysis of human CRC, identifying a strong correlation between expression of the serine protease granzyme A (GzmA) and inflammation. In a dextran sodium sulfate and azoxymethane (DSS/AOM) mouse model, deficiency and pharmacological inhibition of extracellular GzmA both attenuate gut inflammation and prevent CRC development, including the initial steps of cell transformation and epithelial-to-mesenchymal transition. Mechanistically, extracellular GzmA induces NF-κB-dependent IL-6 production in macrophages, which in turn promotes STAT3 activation in cultured CRC cells. Accordingly, colon tissues from DSS/AOM-treated, GzmA-deficient animals present reduced levels of pSTAT3. By identifying GzmA as a proinflammatory protease that promotes CRC development, these findings provide information on mechanisms that link immune cell infiltration to cancer progression and present GzmA as a therapeutic target for CRC. | Descripción: | 8 figures, 1 table.-- Electronic supplementary information available | Versión del editor: | http://dx.doi.org/10.1016/j.celrep.2020.107847 | URI: | http://hdl.handle.net/10261/217477 | DOI: | 10.1016/j.celrep.2020.107847 | ISSN: | 2211-1247 |
Aparece en las colecciones: | (ICB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
j.celrep.2020.107847.pdf | Artículo principal | 5,13 MB | Adobe PDF | Visualizar/Abrir |
j.celrep.2020.107847_info sup.pdf | Información suplementaria | 2,16 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
31
checked on 13-mar-2024
WEB OF SCIENCETM
Citations
30
checked on 24-feb-2024
Page view(s)
269
checked on 28-mar-2024
Download(s)
163
checked on 28-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons